Blog2025-03-18T10:11:14+00:00

AssurX Blog

Straight talk for regulated industries.

1607, 2024

Ensuring Energy Reliability: A Closer Look at NERC’s Framework: Part 2

July 16th, 2024|Energy & Utilities Industry, NERC Compliance, Regulatory Compliance Management|

In part 2 of this blog series, we discuss the importance and impact of regional audits, identify the different regional entities, and describe how they are structured. Regional Audits [...]

907, 2024

A Closer Look at NERC’s Framework for Ensuring Energy Reliability: Part 1

July 9th, 2024|Energy & Utilities Industry, NERC Compliance, Regulatory Compliance Management|

In this 2-part blog series, we will be discussing the current NERC Regional framework for ensuring energy reliability. Highlighting the differences in federal, regional, and Canada ag [...]

2506, 2024

12 Strategies for Successful CAPA Management

June 25th, 2024|Audit Management, Corrective Action (CAPA), FDA Regulated Industries, Food & Beverage Industry, Manufacturing Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management|

There’s no question about it: should an auditor or inspector visit your facility, one thing that will certainly be under the microscope is your corrective and preventive action (CAPA) [...]

1306, 2024

Customer Quality Management: How the QMS Can Help

June 13th, 2024|FDA Regulated Industries, Food & Beverage Industry, Manufacturing Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management|

Customer complaints are a fact of life in any industry. Even though manufacturers would prefer not to receive any complaints, they do come with a silver lining. Managed effectively, t [...]

2905, 2024

The Power of Change Management Tools

May 29th, 2024|FDA Regulated Industries, Food & Beverage Industry, Manufacturing Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management|

Look through even a few FDA warning letters, and you’re likely to find violations related to change management. One recent warning letter, for instance, cited a pharmaceutical manager [...]

Go to Top